Impact of uricosurics on mortality outcomes in patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.

Chia Siang Chia Kow Dinesh Sangarran Ramachandram Syed Shahzad Hasan Kaeshaelya Thiruchelvam

Published in: The International journal of pharmacy practice (2024)

The findings confirmed the safety of uricosurics in COVID-19 patients, despite their potential to cause uric acid excretion, which may possess antioxidant properties.

Keyphrases

uric acid
metabolic syndrome
sars cov
systematic review
oxidative stress
cardiovascular events
anti inflammatory
risk factors
human health
insulin resistance
cardiovascular disease
coronary artery disease
risk assessment
weight loss